1. Home
  2. Clinical Topics
  3. Avastin may lose metastatic breast cancer indication
Clinical TopicsDrugs and DevicesHealthcare & TechnologyNewsOncologyWeb ExclusivesWomen's Health

Avastin may lose metastatic breast cancer indication


An U.S. Food and Drug Administration (FDA)-advisory panel has voted to strip Avastin’s indication for metastatic breast cancer because the drug is not effective for this indication. Final action will be taken by the FDA. Read more here.

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Recent Posts